|Articles|January 15, 2003
- BioPharm International-01-01-2003
- Volume 16
- Issue 1
Outsourcing Outlook: Using Virtual Private Networks to Gain Competitive Advantage
Author(s)Jim Miller, Mark Tuomenoska
by Mark Tuomenoska, OpenReach, Inc. and Jim Miller, Bio/Pharmaceutical Outsourcing Report Outsourcing can be a booster rocket in the race to patent and market innovative products.
Advertisement
Articles in this issue
about 23 years ago
Biotech World: Canada's Supreme Court says "No" to Harvard Mouseabout 23 years ago
Guest Editorial: At the Governance Crossroadabout 23 years ago
Reducing Costs by Facility Designabout 23 years ago
Guidelines for Optimization and Scale-Up in Preparative Chromatographyabout 23 years ago
Survival Strategies: Board Compensation Changing with the TimesNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
FDA October 2025 Draft Guidance Sparks Industry Biosimilars Buzz
2
How Biopharma Navigates the 2026 Economic Shift
3
Adenovirus Vectors, Cyclodextrins and the Patient Experience: A Deep Dive
4
EC’s High-Dose Aflibercept Approval Highlights Durable Anti-VEGF Retinal Therapy
5
